Navigation Links
KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results
Date:8/11/2008

on reported in the first quarter of fiscal 2008.

Ther-Rx Corporation

Ther-Rx net revenues for the first quarter increased 1.7% to $50.9 million compared to $50.1 million in the first quarter of fiscal 2008. The Company anticipates accelerated revenue contribution during the second half of fiscal 2009 from the recent launch of Evamist(TM), as well as from the approval and launch of Gestiva(TM), expected late in calendar 2008. The first quarter increase in branded product sales was due primarily to continued sales growth of our anti-infective brand, Clindesse(R), coupled with increased sales from our hematinic product lines, offset in part by lower sales of Gynazole-1(R).

Evamist(TM)

Having received approval for Evamist(TM) from the FDA in July 2007, the Company has had a successful launch of this patented estradiol transdermal spray that offers a novel approach to the treatment of moderate-to-severe vasomotor symptoms due to menopause. Since the launch in April 2008, Evamist(TM) has continued to show increasing prescription trends and compares favorably to prior analogous product launches in this therapeutic class by other pharmaceutical companies. Based on recent weekly data, total Evamist(TM) prescriptions are trending toward more than 4,000 per month, double the total prescriptions of 2,000 per month during the initial launch period.

By its third month of launch, Evamist(TM) has become the second most prescribed product in the transdermal estrogen category in terms of new patient starts or switches from other brands. Based on IMS weekly 'new-to-brand' prescriptions (NBRx), Evamist(TM) has surpassed all other established branded transdermal patch and topical products with the exception of the leader in this segment, as Evamist(TM) continues to receive positive feedback from physicians and patients alike.

Dr. John Buster, Professor of Obstetrics and Gynecology at the Warren Alpert Medical School of Brown University, is a wel
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2014)... 29, 2014 ... both qualitative and quantitative analysis ... strategies preferred by key market ... the growth, and restraints in ... the opportunities in the baking ...
(Date:11/28/2014)... 2014 The emerging blend ... research in all the healthcare segments such ... support and population health management. The demand ... innovation in machine learning, logical methodologies, computational ... full report with full table of contents ...
(Date:11/28/2014)... Tbdress.com has recently announced its ... on Nov. 28, 2014. The special offer will provide ... more) at greatly discounted prices. , The website ... holiday, celebrated generally on December 25 by billions of ... sales, are always provided in December.” , Tbdress.com ...
(Date:11/28/2014)... Recently, SWAccessControl.com, a renowned smartware manufacturer, has ... all these high end products are offered at discounted ... will last from today to Dec 16, 2014. , ... launch the promotion. We are proud of our new ... latest information about our hottest items, we have listed ...
(Date:11/28/2014)... FL (PRWEB) November 28, 2014 The month ... over 20,000 car accidents occurring in Florida every year ... on the importance of auto insurance policies. , "Optional auto ... drop. Auto insurance is not cheap I know, actually Florida ... the costs are even higher, but what I see is ...
Breaking Medicine News(10 mins):Health News:Global Baking Ingredients Market with an Analysis and Forecast to 2019 - New Research Report Available at ReportsnReports.com 2Health News:Global Baking Ingredients Market with an Analysis and Forecast to 2019 - New Research Report Available at ReportsnReports.com 3Health News:Global Baking Ingredients Market with an Analysis and Forecast to 2019 - New Research Report Available at ReportsnReports.com 4Health News:Medical & Healthcare Analytics Market Report: Global Industry Size, Share, Trends, Growth and Forecast by Researchmoz.us 2Health News:Tbdress.com Announced Its Christmas Eve Sales 2Health News:New Access Control Systems Now Offered At Low Prices By Smartware Manufacturer SWAccessControl.com 2Health News:Car Accident Attorney Sean M. Cleary on Auto Insurance Policies Essential for Florida Drivers 2
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today ... PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment ... the Phase 2 clinical study in late June or ... the clinical trial sites. The U.S. Food and ...
... on Tumors and Tumor Blood Vessel Cells , ... subsidiary of Eisai Corporation of North America, announced that ... investigational new drug (IND) application to study MORAb-004 in ... endosialin, a protein expressed on cells associated with tumors ...
... June 9 Bruce Matter has joined healthcare IT ... for company growth and client satisfaction. Peminic, with offices ... process management solutions to over 400 acute care and ... management and legal matters. , , Teaming with ...
... Million From 2008 to 2018, According to a New Report ... Decision Resources, one of the world,s leading research and ... in the Parkinson,s disease drug market, fueled by the launch ... generic erosion of key currently-available agents. As a result, sales ...
... American Diabetes Association Meeting Validate Mechanistic and Therapeutic Potential ... , , SOUTH SAN FRANCISCO, Calif., June 9 ... three posters that validate the mechanistic activity and therapeutic ... orally-administered soluble epoxide hydrolase (sEH) inhibitor that is in ...
... Four Locations to Hold Discussions on Aging in Place throughout ... , WASHINGTON, June 9 As part of a national ... America will be hosting workshops throughout the month of June, ... Americans remain in their communities. , , Attendees ...
Cached Medicine News:Health News:Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study 2Health News:Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study 3Health News:Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study 4Health News:Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors 2Health News:Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors 3Health News:Industry Recognized and Trusted Leader, Bruce Matter, Joins Healthcare IT Company, Peminic, Inc. as Company Growth in the Areas of Patient Safety, Risk Management, and Patient Satisfaction Accelerates 2Health News:Growth in the Parkinson's Disease Drug Market, Fueled by the Launch of Several New Therapies, Will be Offset by Generic Erosion of Key Agents 2Health News:Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 2Health News:Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 3Health News:Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 4Health News:How Prepared are America's Communities to Handle the Aging Boom? 2Health News:How Prepared are America's Communities to Handle the Aging Boom? 3Health News:How Prepared are America's Communities to Handle the Aging Boom? 4
(Date:11/26/2014)... The medical magnetic resonance imaging (MRI) ... with world market revenues for 2013 at $5.1 ... types of medical imaging have led to improvements ... conditions in children and adults, each imaging procedure ... Medical Imaging Markets , analyzes the current and ...
(Date:11/26/2014)... 2014 According to the ... Source (Electric, Battery, Pneumatic), by Product (Drill, Saw, ... by Application (Orthopedic, ENT, Oral, Thoracic, Neurology) - ... Powered Surgical Instruments Market is estimated to be ... and is expected to grow at a moderate ...
(Date:11/26/2014)... SAN FRANCISCO , Nov. 25, 2014  goBalto, ... solutions, has been recognized as a winner of Red ... received a Global Top 100 North America award in ... the international technology landscape. Red Herring,s Top ... for identifying promising new companies and entrepreneurs. Red Herring ...
Breaking Medicine Technology:Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3
... 2012 What do the leaders of "America,s pastime," a free ... and the founder of Camp Abilities have in common? All ... life for people who are blind or visually impaired, which ... Access Awards, announced today by the American Foundation for the ...
... 27, 2012 A journal for researchers, professionals ... Elsevier , a world-leading provider of scientific, ... announce the launch of the official journal of the Society ... of Applied Research in Memory and Cognition. Published quarterly, ...
Cached Medicine Technology:American Foundation for the Blind Announces 2012 Access Award Winners 2American Foundation for the Blind Announces 2012 Access Award Winners 3Elsevier Launches New Journal: Journal of Applied Research in Memory and Cognition 2
Mounted on a fully adjustable molded,headband with crown strap and comfort,cushions, the sturdy Halogen III Classic is,lightweight, comfortable and durable....
... InterGro DBM putty is a product ... trusted names in human tissue processing, ... bone grafting technology. InterGro combines ... carrier (lecithin) to deliver a unique ...
... The UrinQuick Urine Chemistry Analyzer is a ... of urine test strips. The UrinQuick is ... QuickVue UrinChek 10+ SG and QuickVue UrinChek ... the urine test strips by reflectance spectrophotometry. ...
The NOW Flu A test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results and tre...
Medicine Products: